These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 24138103

  • 1. Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.
    Dalzell JR, Seed A, Berry C, Whelan CJ, Petrie MC, Padmanabhan N, Clarke A, Biggerstaff F, Hillier C, McMurray JJ.
    Cardiovasc Ther; 2014 Feb; 32(1):13-8. PubMed ID: 24138103
    [Abstract] [Full Text] [Related]

  • 2. Vasopeptidase inhibition: a new concept in blood pressure management.
    Burnett JC.
    J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842
    [Abstract] [Full Text] [Related]

  • 3. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC, Pullen MA, Edwards RM, Brooks DP.
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts.
    Blais C, Fortin D, Rouleau JL, Molinaro G, Adam A.
    J Pharmacol Exp Ther; 2000 Nov; 295(2):621-6. PubMed ID: 11046097
    [Abstract] [Full Text] [Related]

  • 5. Vasopeptidase inhibition with omapatrilat increases fluid and protein microvascular permeability in cat skeletal muscle.
    Persson J, Morsing P, Grände PO.
    J Hypertens; 2004 Mar; 22(3):637-44. PubMed ID: 15076171
    [Abstract] [Full Text] [Related]

  • 6. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril.
    Trippodo NC, Fox M, Monticello TM, Panchal BC, Asaad MM.
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):782-90. PubMed ID: 10598120
    [Abstract] [Full Text] [Related]

  • 7. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A, Murata S, Nishio A.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [Abstract] [Full Text] [Related]

  • 8. Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure.
    Maki T, Nasa Y, Tanonaka K, Takahashi M, Takeo S.
    Mol Cell Biochem; 2003 Dec; 254(1-2):265-73. PubMed ID: 14674706
    [Abstract] [Full Text] [Related]

  • 9. Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Nawarskas J, Rajan V, Frishman WH.
    Heart Dis; 2001 Dec; 3(6):378-85. PubMed ID: 11975822
    [Abstract] [Full Text] [Related]

  • 10. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.
    Bäcklund T, Palojoki E, Grönholm T, Eriksson A, Vuolteenaho O, Laine M, Tikkanen I.
    Pharmacol Res; 2001 Nov; 44(5):411-8. PubMed ID: 11712872
    [Abstract] [Full Text] [Related]

  • 11. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG, Yu C, Renner T, Thibodeaux H, Armstrong SR, Park T, Cheruvu M, Olsufka R, Sandvik ER, Lane CE, Budman J, Hill CM, Klein U, Hegde SS.
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [Abstract] [Full Text] [Related]

  • 12. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q, Touyz RM, Schiffrin EL.
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [Abstract] [Full Text] [Related]

  • 13. Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat.
    Kubota E, Dean RG, Hubner RA, Casley DJ, Johnston CI, Burrell LM.
    Clin Sci (Lond); 2003 Sep; 105(3):339-45. PubMed ID: 12741953
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
    Raasch W, Dominiak P, Dendorfer A.
    J Hypertens; 2005 Aug; 23(8):1597-604. PubMed ID: 16003188
    [Abstract] [Full Text] [Related]

  • 15. Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed.
    Dumoulin MJ, Adam A, Rouleau JL, Lamontagne D.
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):359-66. PubMed ID: 11300648
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of neutral endopeptidase by thiorphan does not modify coronary vascular responses to angiotensin I, angiotensin II and bradykinin in the isolated guinea pig heart.
    Kozlovski VI, Lomnicka M, Jakubowski A, Chlopicki S.
    Pharmacol Rep; 2007 Apr; 59(4):421-7. PubMed ID: 17901571
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.
    Lapointe N, Blais C, Adam A, Parker T, Sirois MG, Gosselin H, Clément R, Rouleau JL.
    J Am Coll Cardiol; 2002 May 15; 39(10):1692-8. PubMed ID: 12020499
    [Abstract] [Full Text] [Related]

  • 18. Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension.
    Quaschning T, d'Uscio LV, Shaw S, Viswambharan H, Ruschitzka FT, Lüscher TF.
    Nephrol Dial Transplant; 2001 Jun 15; 16(6):1176-82. PubMed ID: 11390717
    [Abstract] [Full Text] [Related]

  • 19. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E, Jovanoska E, Zafirov D, Jakovski K, Maleska V, Slaninka-Miceska M.
    Bratisl Lek Listy; 2005 Jun 15; 106(12):407-11. PubMed ID: 16642666
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension.
    Maniu CV, Meyer DM, Redfield MM.
    Hypertension; 2002 Oct 15; 40(4):528-34. PubMed ID: 12364358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.